CE-Ventures | Activity | F4

Team Portfolio Raise Champions Essays

F4/CE-Ventures/Activity

CE-Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Exit

Portfolio company Crossbridge Bio to be acquired by Eli Lilly in a deal worth up to $300M.

Crossbridge Bio

Crossbridge Bio CE-Ventures

crescententerprises.com

en.incarabia.com

Added recently

3 investments· NOV 2024 – JAN 2026Show all

Investment

Participated in Think Bioscience's oversubscribed $55M Series A led by Regeneron Ventures, Innovation Endeavors and Janus Henderson Investors.

Think Bioscience

Think Bioscience CE-Ventures

crescententerprises.comJAN 21, 2026

JAN 21, 2026

Investment

Participated in Aalo Atomics' $100M Series B led by Valor Equity Partners.

Aalo Atomics

Aalo Atomics CE-Ventures

crescententerprises.comAUG 2025

AUG 2025

Investment

Co-led Crossbridge Bio's $10M initial financing round.

Crossbridge Bio

Crossbridge Bio CE-Ventures

crescententerprises.comNOV 2024

NOV 2024